2nd International Conference on Immunology and Immunogenetics

Aug 17-18, 2022


Chicago, United States of America

Welcome Message

The "2nd International Conference on Immunology & Immunogenetics" is looking forward to welcome  all attendees. This conference will provide best opportunities, ideas, convictions, strategies, and tactics in a setting unlike any other, with an exceptional lineup of keynote speakers, high-quality and standard participants, and engaging contentThe conference is scheduled to be held in the beautiful city of Chicago, USA on Aug 17-18, 2022 which is also the seat of the most innovative organizationsThe organizing committee and the scientific community at LexisConferences group take immense pleasure in inviting our cardinal participants and speakers from across the world to the 2nd International Conference on Immunology and Immunogenetics held in Chicago, the USA on the 17th and 18th of August 2022.

Plenary sessions

Immunotherapies | Session will draw together learnings from two decades of immunotherapy for immune diseases and cancer. Session will focus on areas such as how useful were preclinical models, biological monitoring, dose, target pathway selection, optimising safety, and administration regimen design and how this should inform more recent approaches to immunotherapy.

Tropical Diseases | Session to highlight immunological vaccine developments and investigations against different tropical diseases.

Brainy Immune System | Session to highlight our understanding of interactions between immune systems, neuronal and the role neuronal signalling plays in shaping the immune response in homeostasis and disease.

Beyond Blood |  Session to highlight advances indirectly sampling from lymph nodes and other tissues to draw more information about the human immune response.

Systems Immunology | Session to highlight the frontiers of systems-based approaches to explore how it is impacting immunology and the clinical medicines.

With its accomplished keynote speakers from several sectors and studious delegates, the conference themed "Immune-based therapeutics for Covid-19 therapy" will undoubtedly be of great importance. Keynote addresses, poster presentations, oral presentations, seminars, workshops, symposia, and exhibitions are all part of the programme

Join us in Chicago, USA for the leading annual all-immunology event worldwide!

Explore the latest developments in your field. | Attend lectures by the world’s most prominent scientists. | Speak with poster authors presenting their cutting-edge data. | Network with colleagues from around the world. | Lectures by active investigators | Keynote forums by renowned immunologists | Poster Sessions on the latest innovations in all relevant areas | Open Innovation Challenges | B2B Meetings

Target audience:

• Immunologists | • Students, scientists, and professors in the field of immunology | • Immunology specialists  |  • Associations and societies in the healthcare field | • Business owners and operators | • Training establishments | • Veterinary professionals | • Immunologists who work with plants | • Surgeons | • Neurologists | • Oncologists | • Bioinformaticians | • Inquisitive minds


Participation Options and Benefits
We provide the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. The mode of participation is webinar through PowerPoint Presentation/ Video Presentation.

Keynote speaker: 45-50 minutes
Speaker (oral presentation): 25-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter:  can present a poster and enjoy the benefits of delegate
Remote attendance:  can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes

Attend Keynote Presentation by world’s most eminent researchers
Access to all the sessions

Get OCM certificate
Get worldwide acknowledgment to your profile and Research
Get your abstracts published with unique DOI in International Journals
Get up to 50% discounts for publishing your entire article in our open access International Journals
Get Handbooks and conference kits
Get an access to the network with eminent personalities from worldwide

Supporting Journals: **All the selected Abstracts/ papers presented will be publish in the Supporting Journals below:

·        Journal Name: Immunochemistry and Immunopathology.

·        Journal Name: Journal of Clinical and Cellular Immunology. 

·        Journal Name: Immunome Research



According to a recent global immunology research, diseases like AIDS are killing more people every day, and the number of new patients diagnosed with infectious diseases is rising at an alarming rate. The global rise in infectious diseases implies that the human body's immune system is weakened, allowing the body to be easily accessed. All of these factors contribute to the conclusion that the rise in infectious diseases will be the primary driver of immunological market growth, and demand for immunological goods will be at an all-time high..

Immunomodulatory are an effective treatment for infectious disorders such as AIDS, as they strengthen the patient's immune system and help them develop resistance to viruses. By 2022, it is expected that the worldwide immunology market would develop at a stable CAGR of around 5%.

New therapeutic compounds have been developed by producers, but they are currently pending regulatory approval. With the launch of these new substances and therapy procedures, the market will reach a new level of development. Manufacturers and scientists are currently concentrating their efforts on developing new advanced immunotherapy medications. In the immunology market, competition is generally centred on price, quality, and innovation.

Both immune suppressants and Immune boosters are sold at nearly the same pace, but immune suppressants have seen a little increase in recent years as the need for anti-transplant rejection medications has grown as a result of the increasing number of organ transplants performed every day. The United States will be the leading income producer due to the country's high level of therapeutic developments.


Dr Ahmed G Hegazi


Ahmed Hegazi is at the present an educator of Microbial science and Immunology within the Public Exploration Place, Egypt. Prof. Hegazi accepted his graduate degree in 1979, and his PhD in 1981. Hegazi's exploration work has been centered recently around honey bee items and their restorative impacts. Dr. Hegazi grants; Top of the road Design of Greatness, Egypt, 1995, The Senior Researcher Prize of Public Exploration Place, Cairo, Egypt, 1996, the general public Logical Award In Natural Sciences, Egypt, 1990,

The Logical Award of the general public Exploration Community, Cairo, Egypt, 1989, the following Best Exploration Paper Grant, Global Congress of Propolis, Bones Aires, Argentina, 2000, Principle Speaker Award,10th Scholastic Meeting, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006, 2 Bronze decorations from The Worldwide Advancement Fair of the middle East, Kuwait, 2007 Granted of Ghazi Wad Allah Salon Prize, 2008.

Granted the Legitimacy Mindful of Clinical Sciences, the general public Exploration Community, 2016. Dr. Hegazi contributed Director of the general public Board for Microbiological Sciences (NCMS) in Egypt, Institute of Science and Innovation, Egypt, from 2018. Hegazi coordinated and added to public and worldwide exploration projects starting around 1977 and up till now; he has been the key agent on numerous examination projects inside the general public Exploration Community.

He Directed instructional classes on Clinical Microbial science, Public Exploration Place in 1979. He has 242 articles publically and worldwide logical diaries. Proofreader in 48 diaries, Ref within the 98 Worldwide Diaries, Coordinator of 114 Global Discussion and meetings, His distributions: 243 articles publicly and worldwide logical diaries, 9 books in West Germanic and 13 books in Semitic. He has patent No. 28335at 11/12/2017. also, registers for other 5

Dr Nazila Bahmaie


Dr Nazila Bahmaie was born in 21th of December 1990 (Iran). She studied BSc of Cellular and Molecular Biology (Major: Microbiology), and MSc of Medical Microbiology (at Zanjan University of Medical Sciences, Iran) which was supervised by Dr. A. Esmaeilzadeh, and graduated as an MSc in September 2016. She started her scientific collaborations and academic research since 2013. Now, she is a PhD candidate of Allergy and Immunology in Near East University, Nicosia, Northern Cyprus, Cyprus. She has worked as an eminent invited speaker for esteemed scientific events and invited authors/reviewer for many scientific journals. Her research interests include Immunology, Infectious Diseases, Cancer, Immunotherapy, Immunopharmacology, Immune Gene and Immune Cell-based Therapy, Drug Delivery, Monoclonal Antibodies, Vaccines, Stem Cells, Regenerative Medicine, and Precision Medicine with 17 scientific published articles, more than 38 presentations in national/international congresses/symposiums, and more than 10 submitted/in progress articles

El Hadji Seydou MBAYE


Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer / World Health Organization, (IARC/WHO), Lyon (France); He obtained a Master’s of Life and Health, Specialty Biology of microorganisms, Virology; a Master’s of Life and Health, option Immuno-physiopathology; a License of Biochemistry in Louis Pasteur University of Strasbourg (France); and a General Degree in Sciences and Technologies in University of METZ (France). He was certified Grade 10/10 by the Federation International of Gynecology Obstetric (FIGO), the Accreditation Council of Oncology in Europe (ACOE), and the Institute Catalan of Oncology (ICO). These credits were recognized as Physician’s Recognition Award (AMA PRA Category 1) by the American Medical Association. He was awarded as International Outstanding Scientist Awards 2020, Awarded as the Best Researcher Award 2021, by VDGOOD. He was certified, by the United Nations, by IARC/WHO. He has published 1 Book with a style of philosophical story. Author of the World Program against Cancer in Low and Middle Incomes Countries, he is lead author of more than 90 peer-reviewed research articles published in reputed journals. Dr. Mbaye is Editor-in-Chief of 4 journals, Editorial Board Member of 157 International Journals, and then he has Edited/Reviewed 234 peer-reviewed articles. He is member of Allied Academies, member of the World Society for Virology (WSV), member of World’s Leading Virologists Group: Facing to Covid-19, member of U.S. National Academies of Sciences, Engineering, and Medicine (NASEM): Societal Experts Action Network (SEAN), and also, member of BCNet International Working Group, IARC/WHO. Dr. MBAYE has formed for free, more than 250 Healthcare Professionals for the techniques of cervical cancer screening in Senegal. He has screened for free more than 2000 women for cervical cancer in Senegal. He appeared on local media, 2S TV, Leeral.net, Mbour TV, Sen TV and 7TV.